CJMB

Callan Jmb Inc.

$0.79 +0.03 (+4.35%) At close · Jul 8

Market Cap

$4.46M

5,646,118

Trades by corporate insiders — officers, directors and holders of more than 10% of the shares — disclosed to the SEC on Forms 3, 4 and 5. Form 4 must be filed within two business days of the trade.

Date	Insider	Role	Type	Security	Shares	Price	Value	After
2026-03-20	Croyle David J	Chief Medical Officer, 10% Owner	Buy	Common Stock (I)	10,195	$1.75	$17,841	800,000
2026-03-06	Croyle David J	Chief Medical Officer, 10% Owner	Buy	Common Stock (I)	14,805	$1.76	$26,086	789,805
2025-12-30	Dial Gerald	Director	Buy	Common Stock	1,539	$1.20	$1,847	2,000
2025-12-30	Dial Gerald	Director	Buy	Common Stock	10,000	$0.76	$7,620	12,000
2025-12-30	Dial Gerald	Director	Buy	Common Stock	461	$1.22	$562	461
2025-12-16	Williams Wayne D	Director, CEO, Chairman and President, 10% Owner	Buy Filing footnotes — Common Stock (Indirect) Mr. Williams is the sole owner of Health Hero America, LLC.	Common Stock (I)	5,000	$1.73	$8,650	84,355
2025-12-15	Williams Wayne D	Director, CEO, Chairman and President, 10% Owner	Buy Filing footnotes — Common Stock (Indirect) Mr. Williams is the sole owner of Health Hero America, LLC.	Common Stock (I)	10,810	$1.70	$18,377	79,355
2025-12-12	Williams Wayne D	Director, CEO, Chairman and President, 10% Owner	Buy	Common Stock	4,926	$1.75	$8,621	2,267,488
2025-12-11	Williams Wayne D	Director, CEO, Chairman and President, 10% Owner	Buy Filing footnotes — Common Stock (Indirect) Mr. Williams is the sole owner of Health Hero America, LLC.	Common Stock (I)	30,856	$1.65	$50,912	68,545
2025-12-11	Williams Wayne D	Director, CEO, Chairman and President, 10% Owner	Buy	Common Stock	62	$1.79	$111	2,262,562
2025-12-10	Williams Wayne D	Director, CEO, Chairman and President, 10% Owner	Buy Filing footnotes — Common Stock (Indirect) Mr. Williams is the sole owner of Health Hero America, LLC.	Common Stock (I)	13,689	$1.65	$22,587	38,689
2025-12-09	Duke Liberty Smith	Director	Buy Filing footnotes — Common Stock (Direct) The reported price is a weighted average price. These shares were purchased in multiple transactions ranging from $1.53 to $1.81, inclusive. The reporting person undertakes to provide Callan JMB Inc., any security holder of Callan JMB Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares bought at each separate price within the range set forth in this footnote to this Form 4	Common Stock	612	$1.52	$930	1,512
2025-12-08	Duke Liberty Smith	Director	Buy	Common Stock	900	$1.56	$1,404	900
2025-03-27	Croyle David J	Chief Medical Officer, 10% Owner	Buy	Common Stock (I)	25,000	$4.50	$112,500	775,000
2025-02-05	Williams Wayne D	Director, CEO, Chairman and President, 10% Owner	Buy Filing footnotes — Common Stock (Indirect) Mr. Williams holds a 41% ownership interest in Warehouse Asset Management, LLC.	Common Stock (I)	25,625	$4.00	$102,500	25,625
2025-02-05	Croyle David J	Chief Medical Officer, 10% Owner	Buy Filing footnotes — Common Stock (Indirect) Mr. Croyle holds a 39% ownership interest in Warehouse Asset Management, LLC.	Common Stock (I)	24,375	$4.00	$97,500	24,375
2025-02-05	Williams Wayne D	Director, CEO, Chairman and President, 10% Owner	Buy Filing footnotes — Common Stock (Indirect) Mr. Williams is the sole owner of Health Hero America, LLC.	Common Stock (I)	25,000	$4.00	$100,000	25,000
2025-02-05	Williams Wayne D	Director, CEO, Chairman and President, 10% Owner	Buy	Common Stock	12,500	$4.00	$50,000	2,262,500
2025-02-04	Dial Gerald	Director	Award Filing footnotes — Option (Right to Buy) (Direct) Granted on the first day of the Initial Public Offering of the Company ("Offering"). The option vests on the first-year anniversary of the closing of the Offering, i.e. February 4, 2026.	Option (Right to Buy)	25,000	$4.00	$100,000	25,000
2025-02-04	Duke Liberty Smith	Director	Award Filing footnotes — Option (Right to Buy) (Direct) Granted on the first day of the Initial Public Offering of the Company ("Offering"). The option vests on the first-year anniversary of the closing of the Offering, i.e. February 4, 2026.	Option (Right to Buy)	25,000	$4.00	$100,000	25,000
2025-02-04	Dial Gerald	Director	Award Filing footnotes — Option (Right to Buy) (Direct) Granted on the first day of the Initial Public Offering of the Company ("Offering"). The option vests on the first-year anniversary of the closing of the Offering, i.e. February 4, 2026.	Option (Right to Buy)	25,000	$4.00	$100,000	25,000

Showing 1–21 of 21 transactions

Key facts CIK 2032545 CUSIP 131100109 Visit website Investor relations